申请人:SMITHKLINE BECKMAN CORPORATION
公开号:EP0250264A1
公开(公告)日:1987-12-23
Substituted β-ethenyl and β-ethynyl benzeneethanamine compounds of structrue (I)
in which X is hydrogen or hydroxy; and R is ethenyl or ethynyl; are potent, irreversible inhibitors of mammalian dopamine-β-hydroxylase. Included are pharmaceutical compositions and methods for using these compounds to inhibit DH, and processes and intermediates used in preparing active compounds.
结构式为(I)的取代 β-乙烯基和 β-乙炔基苯乙胺化合物
其中 X 为氢或羟基;R 为乙烯基或乙炔基;是哺乳动物多巴胺-β-羟化酶的强效不可逆抑制剂。包括使用这些化合物抑制 DH 的药物组合物和方法,以及用于制备活性化合物的工艺和中间体。